Detalhe da pesquisa
1.
MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG).
BMC Cancer
; 21(1): 932, 2021 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407800
2.
Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancer.
Asia Pac J Clin Oncol
; 18(5): e363-e368, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35073441
3.
Performance of serum lipocalin 2 as a diagnostic marker for colorectal cancer.
Cancer Biomark
; 13(2): 75-9, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23838135
4.
PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer.
Clin Cancer Res
; 19(12): 3285-96, 2013 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23633456